Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 32.0% in November

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 40,800 shares, a decrease of 32.0% from the November 15th total of 60,000 shares. Based on an average daily trading volume, of 185,800 shares, the days-to-cover ratio is presently 0.2 days. Approximately 2.3% of the company’s stock are short sold.

Sharps Technology Stock Performance

STSS traded up $0.05 during trading on Friday, hitting $2.04. 101,624 shares of the company traded hands, compared to its average volume of 380,759. Sharps Technology has a one year low of $1.70 and a one year high of $18.15. The firm’s fifty day moving average price is $2.83.

Hedge Funds Weigh In On Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC purchased a new position in Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 9.61% of Sharps Technology as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 17.17% of the company’s stock.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.